Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Sichuan province has reported its first case of HIV-2 infection, marking a rare public health event in China. The finding, ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Orpyx® Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials ...

Argenta Silver Corp. ("Argenta" or the "Company") is pleased to announce the fifth and final set of assay results from its 2025 Winter Diamond Drilling Program (completed mid-September 2025) at its ...

Researchers at the University of Mississippi have found that several minor cannabinoids may help alleviate HIV-associated ...

AdipoR1 selectively recognizes adipokine ligands, differentially shaping T-cell immune outcomes. CTRP9 engages AdipoR1 to ...

Rapid expansion of the global market due to increasing awareness, digital health innovations, and early detection programsAustin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- STD Diagnostics Market Size and ...